A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HD5 / human alpha-defensin 5

[Related PubMed/MEDLINE]
Total Number of Papers: 38
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HD5  (>> Co-occurring Abbreviation)
Long Form:   human alpha-defensin 5
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Human Paneth cell alpha-defensin 5 treatment reverses dyslipidemia and improves glucoregulatory capacity in diet-induced obese mice. IR, NAFLD
2019 Paneth cell alpha-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments. ---
2018 Human Enteric alpha-Defensin 5 Promotes Shigella Infection by Enhancing Bacterial Adhesion and Invasion. ---
2018 Self-Assembling Myristoylated Human alpha-Defensin 5 as a Next-Generation Nanobiotics Potentiates Therapeutic Efficacy in Bacterial Infection. AMP, E. coli, MRSA
2018 The adsorption of human defensin 5 on bacterial membranes: simulation studies. AMPs, LPS, MD
2018 Urinary antimicrobial peptides: Potential novel biomarkers of obstructive uropathy. AMPs, BD-1, HIP/PAP, NGAL, UPJO
2017 Elucidating the Bacterial Membrane Disruption Mechanism of Human alpha-Defensin 5: A Theoretical Study. GN
2017 Human alpha-Defensin 6: A Small Peptide That Self-Assembles and Protects the Host by Entangling Microbes. HD6
2017 In the Wnt of Paneth Cells: Immune-Epithelial Crosstalk in Small Intestinal Crohn's Disease. CD
10  2016 Evaluation of novel urinary tract infection biomarkers in children. AMPs, CI, HNP, LE, UTI
11  2015 A Prospective, Observational Pilot Study of the Use of Urinary Antimicrobial Peptides in Diagnosing Emergency Department Patients With Positive Urine Cultures. AMPs, AUC, ED, hBD-2, HNP1-3, IQR, UTI
12  2015 Alpha-defensin HD5 inhibits furin cleavage of human papillomavirus 16 L2 to block infection. HPV
13  2015 Antimicrobial activity of human alpha-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs. ---
14  2015 Crohn's disease-derived monocytes fail to induce Paneth cell defensins. CD, PBMCs
15  2015 New role for human alpha-defensin 5 in the fight against hypervirulent Clostridium difficile strains. CDI, FACS
16  2015 Visualizing attack of Escherichia coli by the antimicrobial peptide human defensin 5. ---
17  2014 Altered alpha-defensin 5 expression in cervical squamocolumnar junction: implication in the formation of a viral/tumour-permissive microenvironment. HPV, pre, SC
18  2014 Delineation of interfaces on human alpha-defensins critical for human adenovirus and human papillomavirus inhibition. AdV, HNP1, HPV
19  2013 An intrinsically disordered region of the adenovirus capsid is implicated in neutralization by human alpha defensin 5. cryo-EM, HAdV, MDFF
20  2013 Both group 4 capsule and lipopolysaccharide O-antigen contribute to enteropathogenic Escherichia coli resistance to human alpha-defensin 5. AMPs, G4C
21  2013 Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites. HSV-2
22  2012 Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensins. CD, hBD-2, UC
23  2012 Critical determinants of human alpha-defensin 5 activity against non-enveloped viruses. AdV
24  2012 Human alpha defensin 5 expression in the human kidney and urinary tract. AMP
25  2011 Reduced Paneth cell antimicrobial protein levels correlate with activation of the unfolded protein response in the gut of obese individuals. ATF4, BiP, LYZ, UPR
26  2010 Defective paneth cell-mediated host defense in pediatric ileal Crohn's disease. CD, IL-8
27  2010 Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation. CD, HCs, PC, PLA2
28  2009 A role for antimicrobial peptides in intestinal microsporidiosis. hBD-2, HNP1, LF, LZ
29  2009 Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease. CD, HD-6
30  2009 Production of bioactive human alpha-defensin 5 in Pichia pastoris. P. pastoris, PCR, rHD5
31  2008 Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells. BKV, HNP1
32  2008 The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability. ---
33  2006 Human alpha-defensins block papillomavirus infection. HNPs, HPVs
34  2006 Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues. ---
35  2002 Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes. BPI, hBD-1, hBD-2, hBD3, HD6, HNP 1-3, OA, PA, RA, RT-PCR
36  2002 Paneth cell trypsin is the processing enzyme for human defensin-5. ---
37  2001 Detection of natural peptide antibiotics in human nasolacrimal ducts. BPI, hBD-1, hBD-2, HD6, RT-PCR
38  2000 Expression of human alpha-defensin 5 (HD5) mRNA in nasal and bronchial epithelial cells. RT-PCR